Jan Borén

48.0k total citations · 11 hit papers
380 papers, 22.7k citations indexed

About

Jan Borén is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Jan Borén has authored 380 papers receiving a total of 22.7k indexed citations (citations by other indexed papers that have themselves been cited), including 148 papers in Molecular Biology, 101 papers in Endocrinology, Diabetes and Metabolism and 94 papers in Surgery. Recurrent topics in Jan Borén's work include Diabetes, Cardiovascular Risks, and Lipoproteins (67 papers), Liver Disease Diagnosis and Treatment (57 papers) and Lipoproteins and Cardiovascular Health (56 papers). Jan Borén is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (67 papers), Liver Disease Diagnosis and Treatment (57 papers) and Lipoproteins and Cardiovascular Health (56 papers). Jan Borén collaborates with scholars based in Sweden, United Kingdom and United States. Jan Borén's co-authors include Marja‐Riitta Taskinen, Sven‐Olof Olofsson, Kevin Jon Williams, Martin Adiels, S.‐O. Olofsson, Ira Tabas, Chris J. Packard, Marcus Ståhlman, Olov Wiklund and Maria Gustafsson and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Jan Borén

369 papers receiving 22.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lipoprotein(a) as a cardiovascular risk factor: current status

2010 1.3k citations Børge G. Nordestgaard, Jan Borén et al. European Heart Journal profile →
Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis

2007 1.0k citations Kevin Jon Williams, Jan Borén et al. Circulation profile →
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

2011 887 citations M. John Chapman, Jan Borén et al. European Heart Journal profile →
Subendothelial retention of atherogenic lipoproteins in early atherosclerosis

2002 707 citations Jan Borén et al. profile →
Overproduction of Very Low–Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome

2008 593 citations Martin Adiels, Sven‐Olof Olofsson et al. Arteriosclerosis Thrombosis and Vascular Biology profile →
Overproduction of large VLDL particles is driven by increased liver fat content in man

2006 537 citations Martin Adiels, Marja‐Riitta Taskinen et al. profile →
The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity

2016 362 citations Jan Borén, Kevin Jon Williams Current Opinion in Lipidology profile →
Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia

2022 164 citations Jan Borén, Marja‐Riitta Taskinen et al. profile →
Lipoprotein(a) Is Markedly More Atherogenic Than LDL

2024 98 citations Elias Björnson, Martin Adiels et al. Journal of the American College of Cardiology profile →
Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study

2023 97 citations Elias Björnson, Martin Adiels et al. European Heart Journal profile →
Apolipoprotein B-containing lipoproteins in atherogenesis

2025 22 citations Jan Borén et al. profile →

Peers

Countries citing papers authored by Jan Borén

Since Specialization

Citations

This map shows the geographic impact of Jan Borén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Borén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Borén more than expected).

Fields of papers citing papers by Jan Borén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Borén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Borén. The network helps show where Jan Borén may publish in the future.

Co-authorship network of co-authors of Jan Borén

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Borén. A scholar is included among the top collaborators of Jan Borén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Borén. Jan Borén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Integrating deep learning with ECG, heart rate variability and demographic data for improved detection of atrial fibrillation 2025 ·Open Heart ·Araz Rawshani, Aidin Rawshani, (unknown), Jan Borén, (unknown), Mats Börjesson, Johan Engdahl, (unknown), (unknown), Truls Råmunddal, (unknown), Elmir Ömerovic, Zacharias Mandalenakis, (unknown)	0
2	Great debate: Plasma triglycerides are an important causal factor and therapeutic target for atherosclerotic cardiovascular disease 2025 ·European Heart Journal ·Jan Borén, Chris J. Packard, Børge G. Nordestgaard, Alberico L. Catapano	3
3	Synthesis, spectroscopic characterization, DFT and molecular docking of N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl) naphthalene-1-sulfonamide derivatives 2024 ·Journal of Molecular Structure ·Sajda Ashraf, Shazia Iqbal, (unknown), Mehmet Özcan, Woonghee Kim, (unknown), (unknown), (unknown), Cheng Zhang, Mathias Uhlén, Jan Borén, Hasan Türkez, Adil Mardinoğlu	1
4	Lipoprotein(a) Is Markedly More Atherogenic Than LDL breakdown → 2024 ·Journal of the American College of Cardiology ·Elias Björnson, Martin Adiels, Marja‐Riitta Taskinen, Stephen Burgess, M. John Chapman, Chris J. Packard, Jan Borén	98
5	Regulation of meiotic telomere dynamics through membrane fluidity promoted by AdipoR2-ELOVL2 2024 ·Nature Communications ·Jingjing Zhang, Mario Ruiz, Per‐Olof Bergh, Marcus Henricsson, (unknown), Ranjan Devkota, (unknown), Mohammad Bohlooly‐Y, Abrahan Hernández‐Hernández, Manfred Alsheimer, Jan Borén, Marc Pilon, Hiroki Shibuya	7
6	Exploration of Novel Urolithin C Derivatives as Non-Competitive Inhibitors of Liver Pyruvate Kinase 2023 ·Pharmaceuticals ·Umberto Maria Battisti, Leticia Monjas, (unknown), (unknown), (unknown), (unknown), (unknown), Liliana Håversen, Woonghee Kim, Mathias Uhlén, Jan Borén, Adil Mardinoğlu, Morten Grøtli	10
7	Replacing Foods with a High-Glycemic Index and High in Saturated Fat by Alternatives with a Low Glycemic Index and Low Saturated Fat Reduces Hepatic Fat, Even in Isocaloric and Macronutrient Matched Conditions 2023 ·Nutrients ·(unknown), Kay H. M. Roumans, Bas Havekes, Ronald P. Mensink, Harry P. F. Peters, Peter L. Zock, Renée de Mutsert, Jan Borén, Lucas Lindeboom, Patrick Schrauwen, Vera B. Schrauwen‐Hinderling	9
8	Twenty Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study 2023 ·Circulation ·Naveed Sattar, John J.V. McMurray, Jan Borén, Araz Rawshani, Elmir Ömerovic, (unknown), (unknown), (unknown), Björn Eliasson, Hertzel C. Gerstein, Darren K. McGuire, Deepak L. Bhatt, Aidin Rawshani	64
9	Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study breakdown → 2023 ·European Heart Journal ·Elias Björnson, Martin Adiels, Marja‐Riitta Taskinen, Stephen Burgess, Aidin Rawshani, Jan Borén, Chris J. Packard	97
10	Left-Sided Degenerative Valvular Heart Disease in Type 1 and Type 2 Diabetes 2022 ·Circulation ·Araz Rawshani, Naveed Sattar, Darren K. McGuire, (unknown), Ulf Smith, Jan Borén, Göran Bergström, Elmir Ömerovic, Annika Rosengren, Björn Eliasson, Deepak L. Bhatt, Aidin Rawshani	19
11	Postprandial metabolism of apolipoproteins B48, B100, C-III, and E in humans with APOC3 loss-of-function mutations 2022 ·JCI Insight ·Marja‐Riitta Taskinen, Elias Björnson, Niina Matikainen, Sanni Söderlund, Joel Rämö, Mari Ainola, Antti Hakkarainen, Carina Sihlbom, Annika Thorsell, Linda Andersson, Per‐Olof Bergh, Marcus Henricsson, Stefano Romeo, Martin Adiels, Samuli Ripatti, Markku Laakso, Chris J. Packard, Jan Borén	22
12	Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes 2020 ·Arteriosclerosis Thrombosis and Vascular Biology ·Marja‐Riitta Taskinen, Elias Björnson, Juhani Kahri, Sanni Söderlund, Niina Matikainen, Kimmo Porthan, Mari Ainola, Antti Hakkarainen, Nina Lundbom, (unknown), J. Fuchs, Annika Thorsell, Florian Kronenberg, Linda Andersson, Martin Adiels, Chris J. Packard, Jan Borén	19
13	Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans 2020 ·JCI Insight ·Jan Borén, Martin Adiels, Elias Björnson, Niina Matikainen, Sanni Söderlund, Joel Rämö, Marcus Ståhlman, Pietari Ripatti, Samuli Ripatti, Aarno Palotie, Rosellina Margherita Mancina, Antti Hakkarainen, Stefano Romeo, Chris J. Packard, Marja‐Riitta Taskinen	50
14	Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance 2020 ·Nature Communications ·Kay H. M. Roumans, Lucas Lindeboom, Pandichelvam Veeraiah, Carlijn M. E. Remie, Esther Phielix, Bas Havekes, Yvonne M. H. Bruls, Martijn C.G.J. Brouwers, Marcus Ståhlman, Marjan Alssema, Harry P. F. Peters, Renée de Mutsert, Bart Staels, Marja‐Riitta Taskinen, Jan Borén, Patrick Schrauwen, Vera B. Schrauwen‐Hinderling	85
15	Vimentin is required for normal accumulation of body fat 2019 ·Biological Chemistry ·Ulrika Wilhelmsson, Pia Stillemark-Billton, Jan Borén, Milos Pekny	13
16	The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity breakdown → 2016 ·Current Opinion in Lipidology ·Jan Borén, Kevin Jon Williams	362
17	A Mouse Model Reveals an Important Role for Catecholamine-Induced Lipotoxicity in the Pathogenesis of Stress-Induced Cardiomyopathy 2012 ·European Journal of Heart Failure ·Yangzhen Shao, Björn Redfors, Marcus Ståhlman, Margareta Scharin Täng, (unknown), Helge Möllmann, Christian Troidl, Sebastian Szardien, Christian W. Hamm, Holger Nef, Jan Borén, Elmir Ömerovic	80
18	Rip2 Deficiency Leads to Increased Atherosclerosis Despite Decreased Inflammation 2011 ·Circulation Research ·Malin Levin, Pernilla Jirholt, (unknown), Maria E. Johansson, Anna M. Lundberg, Maria Trajkovska, Marcus Ståhlman, Per Fogelstrand, Mikael Brisslert, Linda Fogelstrand, Zhong-qun Yan, Göran K. Hansson, Harry Björkbacka, Sven‐Olof Olofsson, Jan Borén	33
19	Rekrytering av medicinare till forskning kräver tidigt engagemang. Amanuensprogram visar att tidig forskningsstart ger bättre resultat. 2009 ·Chalmers Research (Chalmers University of Technology) ·Jan Borén, Martin Adiels, (unknown), Sven‐Olof Olofsson, Pontus Boström	0
20	Functional Analysis of Disulfide Linkages Clustered within the Amino Terminus of Human Apolipoprotein B 1998 ·Journal of Biological Chemistry ·Khai Tran, Jan Borén, Joseph Macri, Yuwei Wang, Roger S. McLeod, Rita Kohen Avramoglu, Khosrow Adeli, Zemin Yao	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact